CN Stock MarketDetailed Quotes
000930 Cofco Biotechnology
- 5.99
- -0.17-2.76%
Market Closed Dec 13 15:00 CST
11.14BMarket Cap-43.09P/E (TTM)
6.15High5.96Low370.88KlotVolume6.15Open6.16Pre Close223.32MTurnover2.00%Turnover RatioLossP/E (Static)1.86BShares6.8052wk High1.06P/B11.12BFloat Cap4.4252wk Low6.78Limit Up1.86BShs Float28.28Historical High5.54Limit Down3.08%Amplitude0.80Historical Low--Dividend TTM6.02Avg Price200.03KlotAsk--Div YieldTTM100Lot Size169.30KlotBid
Cofco Biotechnology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 2.59%1.67B | -17.24%1.68B | 10.45%1.27B | 45.69%1.48B | 17.02%1.63B | 74.94%2.03B | -13.92%1.15B | -8.90%1.02B | 7.86%1.39B | 4.20%1.16B |
| Notes receivable and accounts receivable | 0.74%1.47B | 12.12%1.09B | -11.20%868.12M | -16.61%1.04B | -4.66%1.46B | -9.86%973.61M | -9.67%977.62M | 47.26%1.25B | 19.19%1.53B | 18.97%1.08B |
| -Notes receivable | 516.96%30.85M | -74.48%773.34K | -87.72%6.3M | -81.65%33.09M | -95.63%5M | --3.03M | --51.3M | --180.38M | --114.39M | ---- |
| -Accounts receivable | -1.04%1.44B | 12.39%1.09B | -6.96%861.82M | -5.61%1.01B | 2.70%1.45B | -10.14%970.58M | -14.41%926.32M | 25.95%1.07B | 10.26%1.41B | 18.97%1.08B |
| Other receivables (including interest and dividends) | -27.67%95.12M | -17.25%102.33M | -31.02%91.88M | 39.15%162.81M | -22.93%131.52M | -46.09%123.65M | -61.57%133.21M | -55.53%117.01M | -23.37%170.65M | -47.35%229.36M |
| -Dividend receivable | --43.43K | -85.10%44.09K | ---- | ---- | ---- | -94.98%296K | ---- | ---- | ---- | 268.80%5.9M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Other receivable | ---- | -17.08%102.28M | ---- | ---- | ---- | -44.80%123.36M | ---- | -55.53%117.01M | ---- | -48.52%223.46M |
| Advance payment | 114.24%644.69M | 67.94%949.43M | 25.29%1.26B | -79.47%225.31M | -18.17%300.92M | -36.16%565.36M | 146.50%1.01B | 554.34%1.1B | 36.88%367.76M | 101.21%885.63M |
| Inventories | -28.85%2.2B | -37.89%3.39B | -50.61%3.4B | -32.66%2.53B | -19.78%3.09B | 6.36%5.46B | 54.26%6.88B | -7.13%3.76B | -4.17%3.85B | -21.06%5.14B |
| Receivable financing | -0.18%117.49M | 116.05%144.09M | 52.17%68.44M | -31.91%83.78M | 195.76%117.7M | -39.14%66.69M | -80.93%44.98M | -64.03%123.05M | -80.28%39.8M | -41.77%109.58M |
| Assets held for sale | ---- | 0.00%20.42M | 0.00%20.42M | 0.00%20.42M | 0.00%20.42M | -65.30%20.42M | -93.02%20.42M | -96.11%20.42M | --20.42M | --58.84M |
| Other current assets | 64.35%604.34M | 81.28%673.89M | 56.11%640.16M | 71.88%485.72M | 26.42%367.71M | 88.61%371.73M | 23.94%410.06M | -11.53%282.59M | -12.55%290.88M | -54.84%197.1M |
| Total current assets | -4.38%6.79B | -16.14%8.06B | -28.30%7.62B | -21.32%6.04B | -7.16%7.11B | 8.54%9.61B | 25.10%10.62B | 0.47%7.67B | 0.57%7.65B | -11.70%8.86B |
| Non Current assets | ||||||||||
| Other equity investment | -7.99%82.02M | -6.93%85.01M | -4.50%81.43M | -2.66%86.57M | -8.27%89.14M | 1.52%91.34M | 4.19%85.26M | -1.60%88.94M | 22.51%97.18M | 22.16%89.97M |
| Long-term equity investment | -2.17%446.99M | -1.41%452.62M | 2.84%449.13M | 0.19%448.81M | -0.50%456.9M | 7.13%459.09M | 5.59%436.72M | 6.22%447.98M | 4.85%459.22M | -1.76%428.52M |
| Fixed assets | ---- | -0.40%8.19B | ---- | ---- | ---- | -2.46%8.22B | ---- | 9.81%8.4B | ---- | 17.75%8.43B |
| Fixed assets liquidation | ---- | 683.99%1.32M | ---- | ---- | ---- | -99.16%168.09K | ---- | -99.13%1.12M | ---- | -97.02%20M |
| Constru in process | ---- | -39.44%94.23M | ---- | ---- | ---- | 50.79%155.58M | ---- | -88.29%84.39M | ---- | -89.91%103.18M |
| Intangible assets | 0.56%604.78M | 0.00%607.01M | 0.08%611.65M | -1.30%601.15M | -1.92%601.45M | -1.90%606.98M | -2.01%611.15M | -3.16%609.08M | -8.55%613.22M | -8.58%618.73M |
| Development expenditure | -2.03%1.17M | 12.72%1.29M | 2.07%1.53M | 2.12%1.53M | 2.06%1.19M | -1.89%1.14M | 29.52%1.5M | 89.69%1.5M | 6.82%1.17M | 7.10%1.17M |
| Goodwill | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M | 0.00%366.04M |
| Long deferred expense | 33.17%44.23M | 32.33%45.43M | 35.29%43.91M | 35.54%40.41M | 7.27%33.21M | 24.81%34.33M | 20.42%32.46M | 21.96%29.81M | 27.00%30.96M | 22.48%27.51M |
| Deferred tax assets | 26.58%253.21M | 40.39%257.37M | 57.63%271.19M | 36.97%265.01M | 27.91%200.04M | 8.07%183.33M | -7.00%172.04M | -4.68%193.49M | 38.44%156.4M | 31.62%169.65M |
| Usufruct assets | 34.31%201.6M | 74.84%206.3M | 78.32%211.15M | 76.52%217.03M | 17.85%150.1M | -10.53%117.99M | -13.24%118.41M | -12.84%122.95M | 560.15%127.36M | 502.93%131.88M |
| Other non current assets | -66.94%39M | -54.70%77.38M | -55.74%81.17M | -26.89%79.98M | 128.69%117.96M | 333.89%170.83M | 319.58%183.4M | 156.62%109.39M | -52.72%51.58M | -71.43%39.37M |
| Total non current assets | 0.55%10.39B | -0.24%10.38B | 0.03%10.44B | 0.61%10.52B | -0.92%10.33B | -0.16%10.41B | 0.27%10.43B | 0.35%10.46B | -3.14%10.43B | -2.73%10.43B |
| Total assets | -1.46%17.18B | -7.88%18.45B | -14.26%18.05B | -8.67%16.56B | -3.56%17.44B | 3.84%20.02B | 11.43%21.06B | 0.40%18.13B | -1.60%18.08B | -7.07%19.28B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -6.00%3.61B | -18.30%4.87B | -18.98%4.77B | 11.91%3.22B | 56.77%3.84B | 59.22%5.96B | 77.94%5.89B | 3.98%2.87B | -6.15%2.45B | -30.42%3.74B |
| Notes payable and accounts payable | 1.35%795.61M | 24.56%914.65M | -14.39%782.02M | -16.65%766.49M | -24.06%784.99M | -18.56%734.33M | 6.87%913.43M | -0.07%919.59M | -26.58%1.03B | -26.99%901.71M |
| -Notes payable | 50.30%81.53M | 382.62%228.9M | 88.42%89.91M | -17.84%84.64M | 10.77%54.25M | -35.49%47.43M | -43.57%47.72M | -18.68%103.02M | -72.74%48.97M | -59.28%73.52M |
| -Accounts payable | -2.28%714.08M | -0.17%685.75M | -20.05%692.11M | -16.50%681.85M | -25.80%730.75M | -17.06%686.9M | 12.41%865.71M | 2.90%816.57M | -19.83%984.79M | -21.46%828.19M |
| Contract liabilities | -45.52%199.41M | -3.82%255.47M | -3.14%303.54M | -4.30%266.39M | -25.79%366M | -47.35%265.61M | -37.49%313.39M | -15.30%278.36M | 5.46%493.2M | 15.55%504.52M |
| Advance receipts | ---- | ---- | ---- | ---- | -99.74%963.42 | --372.38K | --372.38K | --372.38K | --372.38K | ---- |
| Salaries payable | 4.15%170.63M | -24.65%156.43M | -19.16%157.17M | -33.79%154.17M | -10.95%163.82M | 29.97%207.6M | 39.58%194.41M | 17.71%232.86M | -5.47%183.97M | -8.59%159.73M |
| Taxs payable | 6.94%89.92M | 17.77%82.54M | -19.76%77.86M | -19.12%73.88M | -11.08%84.08M | -61.42%70.09M | -28.32%97.04M | 45.25%91.35M | -28.56%94.56M | 2.38%181.68M |
| Other payable (including interest and dividends) | 28.87%662.02M | -41.57%649.04M | -9.17%516.9M | -20.14%541.87M | -33.01%513.72M | 13.67%1.11B | -44.08%569.12M | -42.26%678.52M | -31.04%766.82M | -20.02%977.26M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | --609.83M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 29.55%649.04M | ---- | ---- | ---- | -48.73%501.01M | ---- | -42.26%678.52M | ---- | -15.36%977.26M |
| Non current liabilities due within one year | -8.69%58.79M | 18.90%64.34M | 23.91%62.96M | 17.08%64.1M | 0.19%64.39M | -47.44%54.12M | -50.99%50.81M | -49.03%54.75M | -14.58%64.26M | 45.50%102.96M |
| Other current liabilities | -14.79%35.79M | -14.59%29.01M | -9.04%33.73M | -2.83%30.2M | -23.16%42M | -29.26%33.96M | -25.49%37.08M | -3.99%31.08M | 16.48%54.66M | -9.48%48.01M |
| Total current liabilities | -3.45%5.66B | -16.74%7.03B | -16.67%6.73B | -0.38%5.14B | 13.89%5.86B | 27.51%8.44B | 31.89%8.07B | -7.65%5.16B | -14.85%5.15B | -24.36%6.62B |
| Current liabilities | ||||||||||
| Long term loan | -8.37%190.34M | -20.55%135.77M | -39.74%116.47M | -13.40%165.65M | -17.69%207.72M | -41.04%170.88M | -55.91%193.28M | -52.93%191.28M | -42.57%252.35M | -34.79%289.81M |
| Long term account payable | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 |
| Long term salaries pay | 378.97%64.71M | 123.44%60.41M | 40.96%40.34M | 50.69%41.19M | -60.14%13.51M | -19.59%27.04M | -15.57%28.62M | -21.70%27.33M | -10.40%33.89M | -13.42%33.62M |
| Specific account payable | ---- | 119.07%29.6M | ---- | ---- | ---- | 40.18%13.51M | ---- | -80.95%13.59M | ---- | 63.86%9.64M |
| Deferred tax liabilities | 21.43%83.39M | 41.32%84.7M | 198.34%87.41M | 46.17%89M | 109.64%68.67M | 91.23%59.94M | -1.27%29.3M | 89.87%60.89M | 12.27%32.76M | 4.63%31.34M |
| Long term deferred income | 3.86%60.69M | 10.03%64.76M | 1.80%57.71M | -4.26%56.5M | 16.28%58.44M | 11.50%58.86M | 8.53%56.69M | 15.92%59.01M | -17.02%50.26M | -15.54%52.79M |
| Lease liabilities | 44.14%189.48M | 91.21%193.17M | 86.73%194.96M | 86.16%196.64M | 17.99%131.46M | -8.37%101.02M | -7.71%104.41M | -9.95%105.63M | 1,529.72%111.41M | 1,088.80%110.25M |
| Other non current liabilities | --0 | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | 21.88%618.22M | 31.81%568.4M | 19.85%510.41M | 22.88%562.48M | -13.27%507.22M | -18.24%431.24M | -36.90%425.86M | -35.79%457.74M | -17.46%584.82M | -10.73%527.45M |
| Total liabilities | -1.44%6.28B | -14.38%7.6B | -14.84%7.24B | 1.51%5.7B | 11.12%6.37B | 24.13%8.87B | 25.05%8.5B | -10.83%5.62B | -15.12%5.73B | -23.50%7.15B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.27%1.86B | 0.00%1.86B | 0.00%1.86B | -0.03%1.86B | -0.03%1.86B | -0.03%1.86B | -0.05%1.86B | -0.02%1.87B | -0.02%1.87B | -0.02%1.87B |
| Capital reserve funds | -0.43%6.11B | -0.11%6.13B | -0.10%6.13B | -0.14%6.13B | -0.00%6.13B | 0.01%6.13B | 0.01%6.13B | 0.06%6.13B | -0.01%6.13B | 0.02%6.13B |
| Surplus reserve funds | 25.10%372.73M | 25.10%372.73M | 25.13%372.73M | 25.10%372.73M | 19.21%297.95M | 19.21%297.95M | 19.33%297.88M | 19.21%297.95M | 28.89%249.95M | 9.82%249.95M |
| Retained profit | -18.86%1.42B | -15.79%1.47B | -54.79%1.43B | -55.20%1.41B | -43.60%1.75B | -40.20%1.75B | 7.27%3.16B | 21.31%3.15B | 26.01%3.11B | 33.22%2.93B |
| Less:Treasury stock | -57.41%13.2M | 7.47%33.31M | -18.21%33.31M | -22.59%33.31M | -48.68%31M | -48.68%31M | -39.11%40.73M | -35.67%43.03M | -30.94%60.4M | -30.94%60.4M |
| Other composite income | 13.63%634.18M | -8.11%536.88M | -2.18%538.74M | 4.83%591.42M | 6.23%558.1M | 16.59%584.26M | 15.72%550.75M | 15.59%564.19M | 7.55%525.39M | 0.57%501.12M |
| Ordinary risk reserve funds | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Specific reserves | 0.06%127.15M | -7.92%125.15M | -12.09%119.11M | -8.22%118.08M | -9.41%127.08M | -3.12%135.91M | 3.83%135.5M | -0.12%128.65M | -0.48%140.28M | -5.74%140.29M |
| Shareholders equity without minority interests | -1.81%10.51B | -2.50%10.47B | -13.93%10.42B | -13.61%10.45B | -10.52%10.7B | -8.68%10.73B | 3.14%12.11B | 6.18%12.1B | 6.78%11.96B | 7.05%11.75B |
| Minority interests | 8.26%390.32M | -7.87%383.36M | -12.20%397.91M | -2.33%401.96M | -6.11%360.53M | 9.16%416.1M | 24.45%453.19M | 13.87%411.53M | -7.61%383.98M | -10.41%381.18M |
| Total shareholder equity | -1.48%10.9B | -2.70%10.85B | -13.87%10.82B | -13.24%10.85B | -10.38%11.06B | -8.12%11.15B | 3.78%12.56B | 6.42%12.51B | 6.26%12.34B | 6.39%12.14B |
| Total liabilityies and equity | -1.46%17.18B | -7.88%18.45B | -14.26%18.05B | -8.67%16.56B | -3.56%17.44B | 3.84%20.02B | 11.43%21.06B | 0.40%18.13B | -1.60%18.08B | -7.07%19.28B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
